Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2001-08-08
2008-05-13
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S313000, C514S314000, C514S228200, C514S253060, C544S058200, C544S363000, C546S153000, C546S159000
Reexamination Certificate
active
07371765
ABSTRACT:
The invention relates to compounds of formula (I) wherein: either any one of G1, G2, G3, G4and G5is nitrogen and the other four are —CH—, or G1, G2, G3, G4and G5are all —CH—; Z is —O—, —NH—, —S—, —CH2— or a direct bond; Z is linked to any one of G1, G2, G3and G4; n is an integer from 0 to 5; m is an integer from 0 to 3; Rarepresents hydrogen or fluoro; Rb, R1and R2are defined herein and salt thereof, process for the preparation so such compounds, pharmaceutical compositions containing a compound of formula I or a pharmaceutically acceptable salt thereof as active ingredient and the use of a compound of formula I in the manufacture of a medicament for the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals. The compounds of formula I and the pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of diseases states including cancer and rheumatoid arthritis.
REFERENCES:
patent: 3755332 (1973-08-01), Wasley et al.
patent: 5409930 (1995-04-01), Spada et al.
patent: 5480883 (1996-01-01), Spada et al.
patent: 5646153 (1997-07-01), Spada et al.
patent: RE36256 (1999-07-01), Spada et al.
patent: 6002008 (1999-12-01), Wissner et al.
patent: 6162804 (2000-12-01), Bilodeau et al.
patent: 0326330 (1989-08-01), None
patent: 0 860 433 (1998-08-01), None
patent: 860433 (1998-08-01), None
patent: 1029853 (2000-08-01), None
patent: 2 345 486 (2000-07-01), None
patent: 87/04321 (1987-07-01), None
patent: 92/20642 (1992-11-01), None
patent: 96/30370 (1996-10-01), None
patent: 97/03069 (1997-01-01), None
patent: 97/17329 (1997-05-01), None
patent: 98/02434 (1998-01-01), None
patent: 98/13350 (1998-04-01), None
patent: 98/14431 (1998-04-01), None
patent: WO 98/13350 (1998-04-01), None
patent: WO9813350 (1998-04-01), None
patent: 98/54093 (1998-12-01), None
patent: 99/21859 (1999-05-01), None
patent: 99/35132 (1999-07-01), None
patent: 99/35146 (1999-07-01), None
patent: 00/12497 (2000-03-01), None
patent: 00/18761 (2000-04-01), None
patent: 00/44728 (2000-08-01), None
patent: 01/02369 (2001-01-01), None
AstraZeneca AB
Leeser Erich A.
Wilson James O.
LandOfFree
Quinoline derivatives having VEGF inhibiting activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives having VEGF inhibiting activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives having VEGF inhibiting activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3985380